Promega has a range of products to support research and development of biotherapeutic agents in the Immuno-Oncology field. The products cover the entire workflow from target identification and validation (bioassays), bacterial plasmid generation and purification, antibody development and analysis, high-throughput cell-based functional assays, through to final biotherapeutic quality control assays and companion diagnostic assays. Nucleic Acid and Protein/Antibody Purification with Promega chemistry is supported in high-throughput by our team of Field Support Scientists to ensure that optimum performance is achieved. Promega offers an extensive toolbox of reporter bioassays to characterize and develop novel monoclonal antibody (mAb) and cell-based therapeutics including Immune Checkpoint and T Cell Activation assays. Promega have recently launched a CE-IVD certified Microsatellite Instability (MSI) Analysis kit called OncoMateTM for use in all solid tumours. Please come and visit Promega on stand 7 to discuss how our products can support your workflows.
Live Webinar taking place
Thursday 29th October 2020, 15:00 - 16:00 GMT
Register for the webinar that includes three short presentations on Spatial Biology and one narrated poster. The illustrious presenters will share interesting insights on how to uncover biomarkers in situ and how to deconvolute scRNA data and spatial profiling results in situ.